Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
If this winter is anything like our usual in the North Country, we’re likely to see plenty of downed power lines over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback